<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: MicroRNAs (miRNAs) have been suggested to play a vital role in <z:e sem="disease" ids="C0598935" disease_type="Neoplastic Process" abbrv="">tumor initiation</z:e> and progression by negatively regulating oncogenes and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors </plain></SENT>
<SENT sid="1" pm="."><plain>Quite recently, studies have identified some miRNAs operating to promote or suppress <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion or <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> via regulating <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>-related genes, providing potential therapeutic targets on anti-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> strategy </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastasis</z:e>-associated in <z:hpo ids='HP_0003003'>colon cancer</z:hpo>-1 (MACC1) has been newly identified to express highly in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and promote <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e> through transactivating <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>-inducing HGF/MET signaling pathway </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we investigated whether miRNA 143 is involved in the regulation of MACC1 and thus plays a functional role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Using both in silico prediction and western blot assay, we found the previously reported <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressive miR-143 targeted MACC1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The direct interaction between them was confirmed by 3' UTR luciferase reporter gene </plain></SENT>
<SENT sid="6" pm="."><plain>In concordance with the inhibitory effects induced by siRNA mediated knockdown of MACC1, restoration of miR-143 by mimics in SW620 cells significantly attenuated cell growth, migration and invasion </plain></SENT>
<SENT sid="7" pm="."><plain>It is notable that combined treatment of miR-143 mimics and MACC1 siRNA induced synergistic inhibitory effects compared to either miR-143 mimics or MACC1 siRNA treatment alone </plain></SENT>
<SENT sid="8" pm="."><plain>Conversely, reduction of miR-143 by inhibitors in SW480 cells apparently stimulated these phenotypes </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, we observed that miR-143 level was inversely correlated with MACC1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our findings newly described miR-143/MACC1 link and provided a potential mechanism for MACC1 dysregulation and contribution to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell invasion </plain></SENT>
<SENT sid="11" pm="."><plain>It may help to estimate the therapeutic utility of miR-143 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>